• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ardent Appoints Two New Executive Officers

    10/5/22 3:00:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate
    Get the next $VTR alert in real time by email

    Veteran healthcare executives to lead operations integration and development

    Ardent Health Services today announced the appointment of Carlene Callis as chief system integration and growth officer and Ben Jacobs as chief strategy and development officer.

    "I'm excited to welcome Carlene and Ben to Ardent," said Marty Bonick, president and CEO of Ardent. "As the dynamics of our industry continue to evolve, we need to proactively take the lead in architecting our own future. The addition of two high-performing, proven leaders in these new roles will help us focus on efficiently improving care delivery and expanding accessibility of services to the communities we serve."

    In her role as chief system integration and growth officer, Callis will cross-functionally evaluate all aspects of the organization to create value, leverage scale and better prepare Ardent for the continuing evolution of healthcare delivery. Specifically, she will be responsible for leading key enterprise-wide, growth-enabling functions and identifying and developing processes and "systemness" across Ardent's more than 200 sites of care. With more than 25 years of healthcare experience, Callis has worked as a consultant and health system executive. She joins Ardent following her time at HCA where she served as corporate vice president with responsibility for market growth and development as well as operations of key service lines across the enterprise. Callis holds a bachelor's degree and a masters in healthcare administration from Virginia Commonwealth University.

    "Ardent has become well known for its quality of care and operations excellence as it has grown into new markets," said Callis. "I look forward to working with our leaders and team members to continue enhancing efficiencies, accelerating performance and preparing the organization to better meet the evolving needs of patients and clinicians."

    As chief strategy and development officer, Jacobs will oversee development across Ardent's current markets as well as the organization's entry into new regions and services. He will also be responsible for the company's strategic planning and implementation initiatives, including all hospital and non-hospital transactions. Jacobs brings nearly two decades of strategic development experience in healthcare, including serving as chief strategy and development officer at physical therapy provider Athletico, where he led market expansion for new clinics across the U.S., and chief development officer at Surgery Partners, a national ambulatory surgical center operator. Jacobs is a graduate of Washington and Lee University and holds a JD from Tulane University. As an attorney, he also maintains memberships with the state bar in Texas, Louisiana and Tennessee.

    "Ardent has built a strong track record of growing and improving access to healthcare services in each of its markets to meet the needs of the communities it serves," said Jacobs. "I'm excited to join a team that is committed to transformation and reaching patients in new and innovative ways."

    About Ardent Health Services

    Ardent Health Services invests in people, technology and communities. Through its subsidiaries, Ardent owns and operates 30 hospitals and more than 200 sites of care in six states with more than 24,000 employees, including 1,200+ employed providers. With a focus on evidence-based practices to improve quality care and patient outcomes, four Ardent hospitals were named to Leapfrog's Top Hospitals in 2021 and eight Ardent hospitals received a Leapfrog Hospital Safety Grade of A for Spring 2022. Based in Nashville, Tennessee, Ardent is owned by current and former members of Ardent's management team; Equity Group Investments (EGI), a Chicago-based private investment firm; and Ventas, Inc. (NYSE:VTR), a publicly traded real estate investment trust.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221004006182/en/

    Get the next $VTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VTR

    DatePrice TargetRatingAnalyst
    7/7/2026$99.00Equal Weight
    Barclays
    6/17/2026$94.00Outperform
    Raymond James
    1/9/2026$94.00Buy
    Goldman
    10/1/2025$77.00Overweight
    Cantor Fitzgerald
    9/19/2025$73.00Neutral
    UBS
    6/23/2025$72.00Neutral → Overweight
    Analyst
    3/7/2025Hold → Buy
    Argus
    1/17/2025$66.00 → $65.00Neutral → Outperform
    Robert W. Baird
    More analyst ratings

    $VTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Ventas with a new price target

    Barclays initiated coverage of Ventas with a rating of Equal Weight and set a new price target of $99.00

    7/7/26 8:52:48 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Raymond James resumed coverage on Ventas with a new price target

    Raymond James resumed coverage of Ventas with a rating of Outperform and set a new price target of $94.00

    6/17/26 8:21:14 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Goldman initiated coverage on Ventas with a new price target

    Goldman initiated coverage of Ventas with a rating of Buy and set a new price target of $94.00

    1/9/26 9:07:42 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Maurice S was granted 128 shares, increasing direct ownership by 0.41% to 31,311 units (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    7/17/26 4:16:18 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Director Embler Michael J was granted 72 shares, increasing direct ownership by 0.37% to 19,274 units (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    7/17/26 4:16:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Director Roy Sumit was granted 119 shares, increasing direct ownership by 0.48% to 24,872 units (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    7/17/26 4:16:11 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Embler Michael J bought $197,025 worth of shares (2,500 units at $78.81), increasing direct ownership by 15% to 19,202 units (SEC Form 4)

    4 - Ventas, Inc. (0000740260) (Issuer)

    6/5/26 4:15:26 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

    Ventas, Inc. (NYSE:VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and w

    6/29/26 4:15:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today announced that the Company has named Andrew L. Wattula Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, a wholly-owned property management and leasing subsidiary of Ventas, effective August 2026. He will oversee the Company’s differentiated outpatient medical and research business, which is a leading owner and manager of properties operating at the intersection of medicine, research and universities. He succeeds Peter J. Bulgarelli, who retired from Ventas in May 2026. Wattula brings deep operational, leasing and tenant engagement expertise to Ventas. Working with the Company’s in-

    6/22/26 5:56:00 PM ET
    $VTR
    $HPP
    Real Estate Investment Trusts
    Real Estate
    Finance

    Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

    Ventas, Inc. (NYSE:VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum's 32nd Annual Making History Awards this evening. The Cyrus McCormick Making History Award for Historic Corporate Achievement recognizes business leaders and organizations whose work has made enduring contributions to Chicago's economic and civic life. Under Cafaro's leadership, Ventas has grown into one of the world's leading enterprises at the center of the longevity economy, with ownership of over 1,400 properties and a mission focused on serving a large and growing aging

    6/3/26 4:21:00 PM ET
    $PNC
    $VTR
    Major Banks
    Finance
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Leadership Updates

    Live Leadership Updates

    View All

    Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

    Ventas, Inc. (NYSE:VTR) today announced that Chairman and Chief Executive Officer Debra A. Cafaro will receive the Cyrus McCormick Making History Award for Historic Corporate Achievement at the Chicago History Museum's 32nd Annual Making History Awards this evening. The Cyrus McCormick Making History Award for Historic Corporate Achievement recognizes business leaders and organizations whose work has made enduring contributions to Chicago's economic and civic life. Under Cafaro's leadership, Ventas has grown into one of the world's leading enterprises at the center of the longevity economy, with ownership of over 1,400 properties and a mission focused on serving a large and growing aging

    6/3/26 4:21:00 PM ET
    $PNC
    $VTR
    Major Banks
    Finance
    Real Estate Investment Trusts
    Real Estate

    Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

    Believes NHI is Significantly Undervalued with Opportunities to Unlock its Valuable Assets, Including Upcoming Lease Renewal with Tenant National Healthcare Corporation Highlights Poor Corporate Governance and Serious Conflicts of Interest Among Board Members Expresses Serious Concerns that NHI Board Cannot Fairly Represent Both Landlord and Tenant in Lease Renegotiation Given Substantial Economic and Personal Ties to NHC Discloses Likely Substantial Upside to Lease Rental Rates if Lease is Negotiated at Arms-Length Believes Shareholders Need to Send a Clear Message at Upcoming Annual Meeting – Ahead of Critical Lease Renegotiations – that Maintaining the Status Quo is Not an Option

    4/18/24 9:15:00 AM ET
    $NHC
    $NHI
    $SUI
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Ventas Appoints Theodore Bigman and Joe V. Rodriguez, Jr. to Board of Directors

    Enters Into Cooperation Agreement with Land & Buildings Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has appointed Theodore Bigman and Joe V. Rodriguez, Jr. to the Board, effective immediately. In connection with the appointments, which align with Ventas's ongoing focus on Board refreshment and maintaining strong governance, the Company has entered into a mutual cooperation agreement (the "Cooperation Agreement") with shareholder Land & Buildings Investment Management LLC ("Land & Buildings"). Mr. Bigman brings significant investing and capital markets experience, and has served as a private investor and as founder and Chief Investment Officer of Bigman Holdings,

    3/4/24 8:03:00 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Ventas Inc.

    SC 13G - Ventas, Inc. (0000740260) (Subject)

    10/15/24 1:39:07 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Ventas Inc. (Amendment)

    SC 13G/A - Ventas, Inc. (0000740260) (Subject)

    2/13/24 5:16:09 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Ventas Inc.

    SC 13G - Ventas, Inc. (0000740260) (Subject)

    2/9/24 10:05:20 AM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    SEC Filings

    View All

    Ventas Inc. filed SEC Form 8-K: Leadership Update, Other Events

    8-K - Ventas, Inc. (0000740260) (Filer)

    6/15/26 4:02:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events

    8-K - Ventas, Inc. (0000740260) (Filer)

    5/15/26 5:15:38 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 424B5 filed by Ventas Inc.

    424B5 - Ventas, Inc. (0000740260) (Filer)

    5/15/26 4:51:05 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    $VTR
    Financials

    Live finance-specific insights

    View All

    Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

    Ventas, Inc. (NYSE:VTR) will issue its second quarter 2026 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 29, 2026. A conference call to discuss those earnings will be held on Thursday, July 30, 2026 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com. A telephonic replay will be available at (800) 770-2030 (or +1 (609) 800-9909 for international callers), passcode 7655497, after the earnings call and w

    6/29/26 4:15:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Declares Quarterly Dividend of $0.52 Per Common Share

    Ventas, Inc. (NYSE:VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.52 per common share. The dividend will be payable in cash on July 16, 2026, to stockholders of record as of the close of business on June 30, 2026. About Ventas Ventas, Inc. (NYSE:VTR) is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supp

    5/13/26 4:30:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate

    Ventas Reports 2026 First Quarter Results

    Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the first quarter ended March 31, 2026. CEO Remarks "Ventas delivered excellent first quarter results, powered by our senior housing operating portfolio ("SHOP"). We generated outsized organic growth in SHOP and drove significant occupancy gains, utilizing our differentiated platform, proprietary data and analytics capabilities, operating expertise and industry relationships. As the nearly 70 million Baby Boomers begin turning 80 in 2026, we expect durable demand for our attractive senior housing communities located in favorable markets to increase and provide a sustainable growth and value creation opportuni

    4/27/26 4:10:00 PM ET
    $VTR
    Real Estate Investment Trusts
    Real Estate